戻る
Nykode Therapeutics AS (VACBF)価格
VACBF 株価推移チャート
VACBF 株価予測
Nykode Therapeutics AS
$0
0%
$0
本日現在の状況：Jan 23, 13:09:47 GMT-5
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
39
1株当たり利益(TTM)
-0.03
配当利回り
--
時価総額
--
NYKODE THERAPEUTICS ASAとは何ですか？
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 62 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.